Ceftriaxone Exerts Antitumor Effects in MYCN-Driven Retinoblastoma and Neuroblastoma by Targeting DDX3X for Translation Repression

Using patient-derived tumor organoids and tumor cell lines, investigators demonstrated that ceftriaxone was a potent and selective growth inhibitor targeting MYCN-driven retinoblastoma and neuroblastoma cells.
[Molecular Oncology]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News